ETON - Eton Pharma Near Term Catalysts Vanish
2025-07-15 09:33:40 ET
Eton Pharmaceuticals (NASDAQ: ETON ) operates in the tiny ultra-rare disease niche. I have previously written a deep dive on ETON's business model , in which I argued they are likely to dominate the "orphan drug" space, so for anyone interested in a full description of the company, including risks and valuation, that might be a good place to start....
Eton Pharma Near Term Catalysts Vanish